Life sciences — Patient engagement and real-world evidence with Aide Health

Patient conversations that improve adherence and persistence without adding clinical burden.

Aide has short, daily conversations with patients to support medicine adherence and capture structured data that powers late-phase studies and real-world evidence.

Learn more about Aide

See our impact

Multi-condition coverage

A single digital platform for multiple conditions. Aide enables sponsors and research partners to study complex, comorbid populations without adding clinical burden.

Generate real-world evidence

Aide captures adherence, behavioural data, and PROMs to support Phase IV studies and value demonstration.

Improve adherence and persistence

Our clinically-written conversational AI drives engagement and supports informed, guideline-aligned use at scale.

Study-specific configuration

Customisable modules and patient journeys aligned to trial protocols, registry endpoints, or brand goals.

The ROI of better adherence: 47% increase in realised value

Based on typical real-world adherence for chronic medication, regardless of therapeutic area, (~50%¹) vs. observed 73.3% adherence for patients using Aide².

Treatment (X months × 50% adherence × [monthly value of drug])

Baseline

Treatment with Aide (X months × 73.3% adherence × [monthly value of drug])

+47% uplift per patient

Baseline

Treatment (X months × 50% adherence × [monthly value of drug])

+47% uplift per patient

Treatment with Aide (X months × 73.3% adherence × [monthly value of drug])

Long-term engagement. Reliable real-world evidence.

Aide’s sustained patient interaction delivers continuous behavioural and outcomes data, essential for late-phase studies and value demonstration.

Retention

70%+

30-day patient retention rate of Aide. ~18x digital health app average.³

Patient engagement

Avg. 4

Conversations with Aide per patient per day. Conversations include responses to medicine doses, reporting on symptoms or measurements, PROMs. Without Aide, a patient may only have 3-4 conversations with the healthcare system over the course of a year.

Medicine optimisation

73.3%

Average ICS prescription adherence rate of a patient using Aide (up from 30-50%), paving the way for a potential 10% reduction in severe exacerbations.⁴

Health equity

Age 87

Oldest user managing their health using Aide, with an average age of 52.

Polypharmcy

3.62

Average number of medicines managed per patient in Aide.

See our impact

Trusted by the NHS to support patients nationwide

Aide is already helping thousands of NHS patients manage chronic conditions across multiple Integrated Care Boards. Our existing relationships make it easy to co-develop studies, pilots, and collaborative working initiatives.

Explore partnerships

Currently supporting patients in

Privacy, safety and security

Class I UK Medical Device

Aide is registered as a Class I medical device with the UK regulator and meets the legal safety, performance and quality requirements for medical technologies.

GDPR

Aide is fully compliant with UK GDPR. We complete Data Protection Impact Assessments (DPIAs) to ensure that all personal data is processed lawfully, fairly and transparently.

NHS DTAC assessed

Aide is assessed against the NHS Digital Technology Assessment Criteria (DTAC) and meets NHS standards for clinical safety, data protection, cybersecurity, and accessibility.

Cyber Essentials Plus

Aide is independently certified to Cyber Essentials Plus, the government-backed standard for cybersecurity. Our systems are secure and protected against common cyber threats.

Frequently asked questions

Eliasson L, Clifford S, Barber N, Marin D. Exploring chronic medication adherence in the UK: a longitudinal analysis of prescription data from 2010 to 2017. BMJ Open. 2020;10(1):e034514. doi:10.1136/bmjopen-2019-034514
Aide internal data with Suffolk Primary Care (2024)
AppsFlyer. 2024
Engelkes, Marjolein, et al. "Medication Adherence and the Risk of Severe Asthma Exacerbations: A Systematic Review." European Respiratory Journal, vol. 45, no. 2, Feb. 2015, pp. 396-407. European Respiratory Society, doi:10.1183/09031936.00075614.

Aide Health launches the first AI note-taker for patients

Patient engagement for research and real-world evidence

Rich, real-world data